
NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …

Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …
Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …